RASUVO 20 MG/0.4 ML AUTOINJ

methotrexate
$361.0280per ML
High Outlier

Strength

20 mg/.4mL

NDC

59137053004

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/1/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA205776

On Market Since

7/10/2014

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+2.6%

6M

+2.6%

1Y

+2.7%

3Y

+9.6%

5Y

+20.2%

All

+7.0%